Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 1840513, 11 pages
http://dx.doi.org/10.1155/2016/1840513
Research Article

Low-ω3 Fatty Acid and Soy Protein Attenuate Alcohol-Induced Fatty Liver and Injury by Regulating the Opposing Lipid Oxidation and Lipogenic Signaling Pathways

Lipid Research Laboratory, VA Medical Center and Department of Biochemistry and Molecular Medicine, The George Washington University, Washington, DC, USA

Received 5 August 2016; Revised 14 October 2016; Accepted 15 November 2016

Academic Editor: Tullia Maraldi

Copyright © 2016 Karina Reyes-Gordillo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. E. Cojocariu, A. V. Trifan, I. Gîrleanu, and C. Stanciu, “Alcoholic liver diseas—epidemiology and risk factors,” Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, vol. 118, no. 4, pp. 910–917, 2014. View at Google Scholar
  2. J.-Y. Zhou, Z.-A. Jiang, C.-Y. Zhao, Z. Zhen, W. Wang, and A. A. Nanji, “Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver,” Alcoholism: Clinical and Experimental Research, vol. 37, no. 2, pp. 213–222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Zeng and K.-Q. Xie, “Ethanol and liver: recent advances in the mechanisms of ethanol-induced hepatosteatosis,” Archives of Toxicology, vol. 83, no. 12, pp. 1075–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Lakshman, “Some novel insights into the pathogenesis of alcoholic steatosis,” Alcohol, vol. 34, no. 1, pp. 45–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. E. E. Mulvihill and M. W. Huff, “Protection from metabolic dysregulation, obesity, and atherosclerosis by citrus flavonoids: activation of hepatic PGC1α-mediated fatty acid oxidation,” PPAR Research, vol. 2012, Article ID 857142, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Nagai, S. Yonemitsu, D. M. Erion et al., “The role of peroxisome proliferator-activated receptor γ coactivator-1 β in the pathogenesis of fructose-induced insulin resistance,” Cell Metabolism, vol. 9, no. 3, pp. 252–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Tachibana, Y. Kobayashi, T. Tanaka et al., “Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms,” Nuclear Receptor, vol. 3, article 3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. E. E. Girroir, H. E. Hollingshead, P. He, B. Zhu, G. H. Perdew, and J. M. Peters, “Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARβ/Δ) protein in mice,” Biochemical and Biophysical Research Communications, vol. 371, no. 3, pp. 456–461, 2008. View at Publisher · View at Google Scholar
  9. T. Varga, Z. Czimmerer, and L. Nagy, “PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1812, no. 8, pp. 1007–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Peters, J. E. Foreman, and F. J. Gonzalez, “Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis,” Cancer and Metastasis Reviews, vol. 30, no. 3-4, pp. 619–640, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. M. Spiegelman, “Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators,” Novartis Foundation Symposium, vol. 287, pp. 60–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Nemoto, M. M. Fergusson, and T. Finkel, “SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α,” Journal of Biological Chemistry, vol. 280, no. 16, pp. 16456–16460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Li, S. Xu, M. M. Mihaylova et al., “AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice,” Cell Metabolism, vol. 13, no. 4, pp. 376–388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Carradori, D. Secci, and A. Mai, “Epigenetic modulation of PGC-1α activity by GCN5 inhibitors: WO2010007085,” Expert Opinion on Therapeutic Patents, vol. 21, no. 10, pp. 1651–1656, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. You, Q. Cao, X. Liang, J. M. Ajmo, and G. C. Ness, “Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice,” Journal of Nutrition, vol. 138, no. 3, pp. 497–501, 2008. View at Google Scholar · View at Scopus
  17. J. B. Kim and B. M. Spiegelman, “ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism,” Genes and Development, vol. 10, no. 9, pp. 1096–1107, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Shimano, J. D. Horton, R. E. Hammer, I. Shimomura, M. S. Brown, and J. L. Goldstein, “Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a,” Journal of Clinical Investigation, vol. 98, no. 7, pp. 1575–1584, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Burckhardt, M. Herke, T. Wustmann, S. Watzke, G. Langer, and A. Fink, “Omega-3 fatty acids for the treatment of dementia,” The Cochrane Database of Systematic Reviews, vol. 4, Article ID CD009002, 2016. View at Google Scholar
  20. K. S. Montgomery, “Soy protein,” The Journal of Perinatal Education, vol. 12, no. 3, pp. 42–45, 2003. View at Google Scholar
  21. W. X. Chao, “Health effects of soy protein and isoflavones in humans,” Journal of Nutrition, vol. 138, no. 6, pp. 1244S–1249S, 2008. View at Google Scholar · View at Scopus
  22. D. Cutuli, “Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging,” Current Neuropharmacology, vol. 14, no. 8, 2016. View at Publisher · View at Google Scholar
  23. B. E. Phillipson, D. W. Rothrock, W. E. Connor, W. S. Harris, and D. R. Illingworth, “Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia,” The New England Journal of Medicine, vol. 312, no. 19, pp. 1210–1216, 1985. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-C. Yang, S.-M. Liu, H.-Y. Yang, Y.-H. Lin, and J.-R. Chen, “Soybean protein hydrolysate improves plasma and liver lipid profiles in rats fed high-cholesterol diet,” Journal of the American College of Nutrition, vol. 26, no. 5, pp. 416–423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Hashidume, T. Sasaki, J. Inoue, and R. Sato, “Consumption of soy protein isolate reduces hepatic SREBP-1c and lipogenic gene expression in wild-type mice, but not in FXR-deficient mice,” Bioscience, Biotechnology and Biochemistry, vol. 75, no. 9, pp. 1702–1707, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. J. Ronis, Y. Chen, J. Badeaux, and T. M. Badger, “Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling,” The Journal of Nutrition, vol. 139, no. 8, pp. 1431–1438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. R. Tovar, I. Torre-Villalvazo, M. Ochoa et al., “Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats,” Journal of Lipid Research, vol. 46, no. 9, pp. 1823–1832, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. C. S. Lieber and L. M. DeCarli, “The feeding of alcohol in liquid diets: two decades of applications and 1982 update,” Alcoholism: Clinical and Experimental Research, vol. 6, no. 4, pp. 523–531, 1982. View at Publisher · View at Google Scholar · View at Scopus
  29. P. G. Reeves, F. H. Nielsen, and G. C. Fahey Jr., “AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet,” The Journal of Nutrition, vol. 123, no. 11, pp. 1939–1951, 1993. View at Google Scholar · View at Scopus
  30. L. I. Gidez, G. J. Miller, M. Burstein, S. Slagle, and H. A. Eder, “Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure,” Journal of Lipid Research, vol. 23, no. 8, pp. 1206–1223, 1982. View at Google Scholar · View at Scopus
  31. M. Burstein, H. R. Scholnick, and R. Morfin, “Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions,” Journal of Lipid Research, vol. 11, no. 6, pp. 583–595, 1970. View at Google Scholar · View at Scopus
  32. C. C. Allain, L. S. Poon, and C. S. G. Chan, “Enzymatic determination of total serum cholesterol,” Clinical Chemistry, vol. 20, no. 4, pp. 470–475, 1974. View at Google Scholar · View at Scopus
  33. M. W. McGowan, J. D. Artiss, D. R. Strandbergh, and B. Zak, “A peroxidase-coupled method for the colorimetric determination of serum triglycerides,” Clinical Chemistry, vol. 29, no. 3, pp. 538–542, 1983. View at Google Scholar · View at Scopus
  34. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Zlatkis and B. Zak, “Study of a new cholesterol reagent,” Analytical Biochemistry, vol. 29, no. 1, pp. 143–148, 1969. View at Publisher · View at Google Scholar · View at Scopus
  36. S. K. Basu, J. L. Goldstein, G. W. Anderson, and M. S. Brown, “Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 73, no. 9, pp. 3178–3182, 1976. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Varatharajalu, M. Garige, L. C. Leckey et al., “Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat,” The American Journal of Pathology, vol. 184, no. 7, pp. 2035–2044, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. J. T. Rodgers, C. Lerin, W. Haas, S. P. Gygi, B. M. Spiegelman, and P. Puigserver, “Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1,” Nature, vol. 434, no. 7029, pp. 113–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Rakhshandehroo, S. Kersten, B. Knoch, and M. Müller, “Peroxisome proliferator-activated receptor alpha target genes,” PPAR Research, vol. 2010, Article ID 612089, 20 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Satoh, L. Stein, and S. Imai, “The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity,” Handbook of Experimental Pharmacology, vol. 206, pp. 125–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. S. Lieber, M. A. Leo, X. Wang, and L. M. DeCarli, “Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1α in rats,” Biochemical and Biophysical Research Communications, vol. 370, no. 1, pp. 44–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Fischer, M. You, M. Matsumoto, and D. W. Crabb, “Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice,” The Journal of Biological Chemistry, vol. 278, no. 30, pp. 27997–28004, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Enomoto, Y. Takei, M. Hirose et al., “Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-γ, pioglitazone,” Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 3, pp. 846–854, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Tomita, T. Azuma, N. Kitamura et al., “Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met,” Gastroenterology, vol. 126, no. 3, pp. 873–885, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. A. A. Nanji, S. M. Hossein Sadrzadeh, E. K. Yang, F. Fogt, M. Meydani, and A. J. Dannenberg, “Dietary saturated fatty acids: a novel treatment for alcoholic liver disease,” Gastroenterology, vol. 109, no. 2, pp. 547–554, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. M. J. J. Ronis, S. Korourian, M. Zipperman, R. Hakkak, and T. M. Badger, “Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition,” Journal of Nutrition, vol. 134, no. 4, pp. 904–912, 2004. View at Google Scholar · View at Scopus
  47. B.-J. Song, K.-H. Moon, N. U. Olsson, and N. Salem Jr., “Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids,” Journal of Hepatology, vol. 49, no. 2, pp. 262–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. L.-L. Huang, J.-B. Wan, B. Wang et al., “Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 88, no. 5, pp. 347–353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Wada, T. Yamazaki, Y. Kawano, S. Miura, and O. Ezaki, “Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice,” Journal of Hepatology, vol. 49, no. 3, pp. 441–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. M. You, M. Fischer, M. A. Deeg, and D. W. Crabb, “Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP),” The Journal of Biological Chemistry, vol. 277, no. 32, pp. 29342–29347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. H. Ki, J. H. Choi, C. W. Kim, and S. G. Kim, “Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity,” Chemico-Biological Interactions, vol. 169, no. 2, pp. 80–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Lu, J. Zhuge, X. Wang, J. Bai, and A. I. Cederbaum, “Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice,” Hepatology, vol. 47, no. 5, pp. 1483–1494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Zeng, C.-L. Zhang, F.-Y. Song, X.-L. Zhao, and K.-Q. Xie, “CMZ reversed chronic ethanol-induced disturbance of PPAR-α possibly by suppressing oxidative stress and PGC-1α acetylation, and activating the MAPK and GSK3β pathway,” PLoS ONE, vol. 9, no. 6, Article ID e98658, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Tsukamoto, S. J. Towner, L. M. Ciofalo, and S. W. French, “Ethanol-induced liver fibrosis in rats fed high fat diet,” Hepatology, vol. 6, no. 5, pp. 814–822, 1986. View at Publisher · View at Google Scholar · View at Scopus
  55. S. W. French, “Nutrition in the pathogenesis of alcoholic liver disease,” Alcohol and Alcoholism, vol. 28, no. 1, pp. 97–109, 1993. View at Google Scholar · View at Scopus
  56. A. A. Nanji, C. L. Mendenhall, and S. W. French, “Beef fat prevents alcoholic liver disease in the rat,” Alcoholism: Clinical and Experimental Research, vol. 13, no. 1, pp. 15–19, 1989. View at Publisher · View at Google Scholar · View at Scopus
  57. M. R. Lakshman, S. J. Chirtel, and L. L. Chambers, “Roles of ω3 fatty acids and chronic ethanol in the regulation of plasma and liver lipids and plasma apoproteins A1 and E in rats,” Journal of Nutrition, vol. 118, no. 11, pp. 1299–1303, 1988. View at Google Scholar · View at Scopus
  58. P. Marmillot, M. N. Rao, Q.-H. Liu, S. J. Chirtel, and M. R. Lakshman, “Effect of dietary omega-3 fatty acids and chronic ethanol consumption on reverse cholesterol transport in rats,” Metabolism: Clinical and Experimental, vol. 49, no. 4, pp. 508–512, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. M. N. Rao, Q.-H. Liu, P. Marmillot, L. B. Seeff, D. B. Strader, and M. R. Lakshman, “High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function,” Metabolism: Clinical and Experimental, vol. 49, no. 11, pp. 1406–1410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. C. S. Lieber, L. M. DeCarli, K. M. Mak, C.-I. Kim, and M. A. Leo, “Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin,” Hepatology, vol. 12, no. 6, pp. 1390–1398, 1990. View at Publisher · View at Google Scholar · View at Scopus
  61. C. S. Lieber, S. J. Robins, L. Jianjun et al., “Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon,” Gastroenterology, vol. 106, no. 1, pp. 152–159, 1994. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Marmillot, S. Patel, and M. R. Lakshman, “Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins,” Metabolism: Clinical and Experimental, vol. 56, no. 2, pp. 251–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. W. S. Davidson, K. L. Gillotte, S. Lund-Katz, W. J. Johnson, G. H. Rothblat, and M. C. Phillips, “The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol,” The Journal of Biological Chemistry, vol. 270, no. 11, pp. 5882–5890, 1995. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Marmillot, J. Munoz, S. Patel, M. Garige, R. B. Rosse, and M. R. Lakshman, “Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans,” Metabolism: Clinical and Experimental, vol. 56, no. 7, pp. 947–953, 2007. View at Publisher · View at Google Scholar · View at Scopus